AstraZeneca Plans Mega Investment in the USA: $50 Billion by 2030
Reading Time: 2 minutes
AstraZeneca has announced plans to invest $50 billion in the USA by 2030. This makes it the latest pharmaceutical company to commit to American production, as looming tariffs could drive up costs across the industry. Focus on chronic diseases and weight management The biopharmaceutical company announced on July 21, 2025, that the investment includes plans for a new manufacturing center focused on chronic diseases. The multibillion-dollar facility would support the company’s portfolio for weight management and metabolic disorders, including...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
